Perioperative immunity: is there an anaesthetic hangover?
نویسنده
چکیده
receptor blocker withdrawal. A preoperative problem in general surgery? Acta Anaesthesiol Scand Suppl 1982; 76: 32–7 26 Crandell DL. The anesthetic hazards in patients on antihypertensive therapy. J Am Med Assoc 1962; 179: 495–500 27 Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg 1972; 64: 826–30 28 Ellenberger C, Tait G, Beattie WS. Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: a single-center propensity-matched cohort study. Anesthesiology 2011; 114: 817–23 29 Poldermans D. Scientific fraud or a rush to judgment? Am J Med 2013; 126: e5–6 30 Chopra V, Eagle KA. Perioperative mischief: the price of academic misconduct. Am J Med 2012; 125: 953–5 31 Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomised controlled trials of b-blockade to prevent perioperative death in non-cardiac surgery. Heart Online 2013 Advance Access published on 31 July 2013, doi: 10.1136/heartjnl2013-304262 32 Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789–94 33 Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoingnoncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009; 249: 921–6 34 Wallace AW, Au S, Cason BA. Perioperative beta-blockade: atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011; 114: 824–36 35 Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349–61 36 London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative beta-blockadewith mortalityand cardiovascular morbidity following major noncardiac surgery. J Am Med Assoc 2013; 309: 1704–13 37 Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008; 106: 1039–48 38 Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010; 112: 25–33 39 Le Manach Y, Collins GS, Ibanez C, et al. Impact of perioperative bleeding on the protective effect of beta-blockers during infrarenal aortic reconstruction. Anesthesiology 2012; 117: 1203–11 40 ACCF/AHA, ESC. Joint Statement: issued by the American College of Cardiology, American Heart Association and the European Society of Cardiology. 2013. Available from www.escardio.org.about/ press/press-releases/pr-13/Pages/joint-statement-perioperativeguidelines.aspx (accessed 10 August 2013)
منابع مشابه
Effect of anaesthetic technique and other perioperative factors on cancer recurrence.
Surgical excision is the mainstay of treatment for potentially curable solid tumours. Metastatic disease is the most important cause of cancer-related death in these patients. The likelihood of tumour metastases depends on the balance between the metastatic potential of the tumour and the anti-metastatic host defences, of which cell-mediated immunity, and natural killer cell function in particu...
متن کاملCore outcome measures in perioperative and anaesthetic care
Background There is no current consensus within the anaesthetic and perioperative research community on what outcomes are important, nor how to measure them. This leads to heterogeneity of outcome reporting in randomised controlled trials (RCTs), and selective outcome reporting – i.e. a bias towards reporting only statistically significant outcomes [1]. Here we describe an initiative to develop...
متن کاملCan anaesthetic and analgesic techniques affect cancer recurrence or metastasis?
Cancer is a leading cause of morbidity and mortality worldwide and the ratio of incidence is increasing. Mortality usually results from recurrence or metastases. Surgical removal of the primary tumour is the mainstay of treatment, but this is associated with inadvertent dispersal of neoplastic cells into the blood and lymphatic systems. The fate of the dispersed cells depends on the balance of ...
متن کاملAlthesin--a new intravenous anaesthetic.
IN 1941, Selye 1 noted the anaesthetic effect of some steroids in animals. Fourteen years later, Murphy e t al . 2 reported on the use of a steroid hydroxydione to produce clinical anaesthesia. This agent, when given intravenously, has a gradual onset of action and produces prolonged sleep with little disturbance to the cardiovascular and respiratory systems and no hangover effect. Unfortunatel...
متن کاملThe perioperative immune response.
PURPOSE OF REVIEW A host of immune modulators are now available in clinical practice. The perioperative period is characterized by profound alterations in host immunity, which can result in poor outcomes, which include infection, cancer recurrence and organ failure. Manipulation of the perioperative immune response has the potential to improve outcomes. A complete understanding of the mechanism...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014